In line with our findings, Johnson et al. observed that patients with recurrent SCCHN tended to have higher proportions of circulating CD8+ cytotoxic T cells at diagnosis than patients who remained disease-free [23]. The gene discussed is CD8A; the disease is head and neck squamous cell carcinoma.